Evidence map›Paper›PMID 36463779›Full record

ArticleEBioMedicine2022

Single-cell genomics identifies immune response to neoadjuvant chemoradiotherapy.

Uttam K Sinha, W Martin Kast, De-Chen Lin

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Uttam K SinhaDepartment of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA. Electronic address: sinha@med.usc.edu.
W Martin KastDepartment of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA; Department of Molecular Microbiology & Immunology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, USA.
De-Chen LinCenter for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA. Electronic address: dechenli@usc.edu.

Funding

Master regulator transcription factors promote esophageal neoplastic evolutionR37CA237022 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIN, DE-CHEN · 2020 to 2025
$2.7M
NCI NIH HHS R37 CA237022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Esophageal NeoplasmsRectal NeoplasmsChemoradiotherapyGenomicsHumansImmunityNeoadjuvant TherapyRetrospective StudiesTreatment Outcome

Identifiers

PMID36463779
PMCPMC9718959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.